FDA
-
-
-
-
-
-
-
Lilly to present 16 Alzheimer's abstracts at AAIC 2026 in London
-
-
-
-
-
-
-
Lilly's Jaypirca gets EU approval recommendation for CLL
-
-
-
-
-
-
-
Zepbound (tirzepatide) and Shaquille O'Neal launch national campaign after NBA legend learns the obstructive sleep apnea he has lived with for years is treatable
-
-
-
-
-
-
-
Eli Lilly reports positive results for obesity drug retatrutide trials
-
-
-
-
-
-
-
Lilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant therapy for people with early-stage RET fusion-positive lung cancer
-
-
-
-
-
-
-
Lilly to present oncology data at ASCO 2026 meeting
-
-
-
-
-
-
-
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
-
326,104 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

